Nov 29, 2023

Partner of Choice: Aitia and Servier Revolutionize the Landscape of Pancreatic Cancer Treatment

Spotlight on our joint effort with Servier to advance the discovery and simulation of drugs for Pancreatic Cancer. This strategic partnership aims to delve into the intricate mechanisms of this complex disease, with the goal of expediting the development of innovative therapies for individuals affected by pancreatic cancer.

Read what Servier had to say about his “Partner of Choice” in this article.